| __timestamp | Celldex Therapeutics, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 101881000 | 2395000 |
| Thursday, January 1, 2015 | 4011000 | 9057000 |
| Friday, January 1, 2016 | 102026000 | 393000 |
| Sunday, January 1, 2017 | 96171000 | 79309000 |
| Monday, January 1, 2018 | 66449000 | 134428000 |
| Tuesday, January 1, 2019 | 42672000 | 175431000 |
| Wednesday, January 1, 2020 | 42534000 | 124165000 |
| Friday, January 1, 2021 | 3068000 | 121875000 |
| Saturday, January 1, 2022 | 1400000 | 10114000 |
| Sunday, January 1, 2023 | 3008000 | 9206000 |
Data in motion
In the dynamic world of biotechnology, understanding financial trends is crucial for investors and stakeholders. This analysis focuses on the cost of revenue for two pioneering companies: Celldex Therapeutics, Inc. and Wave Life Sciences Ltd. over the past decade.
From 2014 to 2023, Celldex Therapeutics experienced significant fluctuations, with a peak cost of revenue in 2016, reaching nearly 100% more than its lowest point in 2022. Meanwhile, Wave Life Sciences showed a steady increase, peaking in 2019 with a cost of revenue over 70 times higher than in 2014.
These trends highlight the volatile nature of the biotech industry, where research and development costs can vary dramatically year over year. Investors should consider these patterns when evaluating the financial health and strategic direction of these companies.
Cost of Revenue Trends: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: GSK plc vs Wave Life Sciences Ltd.
Cost of Revenue Comparison: Bio-Techne Corporation vs Wave Life Sciences Ltd.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost Insights: Breaking Down Exelixis, Inc. and Wave Life Sciences Ltd.'s Expenses
Comparing Cost of Revenue Efficiency: Halozyme Therapeutics, Inc. vs Celldex Therapeutics, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc.
Cost of Revenue Trends: Perrigo Company plc vs Celldex Therapeutics, Inc.
Cost of Revenue Trends: Veracyte, Inc. vs Celldex Therapeutics, Inc.
Cost of Revenue Comparison: MorphoSys AG vs Celldex Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Wave Life Sciences Ltd.